GxP compliance is shown by approved procedures together with the records and evidence that they are followed consistently. Keeping procedures, systems, responsibilities and execution aligned makes inspections routine. IGX360 Insights gives pharmaceutical and biotechnology organisations one evidenced view of their documented processes and the records that support them.
In your words: “We do not know how work really happens”
A governed, connected view of how work runs gives every team the same starting point. It replaces individual descriptions with one baseline that can be queried, owned and kept current.
In your words: “Our process knowledge is fragmented and untrusted”
Content held across Visio, SharePoint, SOPs and spreadsheets works as one source once versions, owners and dates are visible. Then people know which version is authoritative and who to ask.
In your words: “We think we are compliant but cannot prove it”
Traceability from obligation through process, owner, system, control and retained evidence lets you show how a duty is met, whenever you are asked.
In your words: “Our documented process is not how the work actually gets done”
When the process model and daily execution are connected, the model stays useful and governance reflects real work. Approved workarounds become part of the design.
In your words: “Our systems tell us what happened, but not why the process failed or what to change”
When execution evidence is retained and connected, the organisation can see not just what happened but why, and what to change.
In your words: “Risks, controls, processes and obligations are disconnected”
A connected process-centric risk model shows which processes create each risk, which controls operate within them and where coverage can be strengthened.
In your words: “When regulations change, we cannot quickly identify every process, control, system and role affected”
Connected impact analysis identifies affected processes, systems, controls, roles and suppliers consistently, so implementation starts from a complete list.
In your words: “EMA and EU medicines requirements are difficult to embed and evidence”
Connecting procedures, roles, systems, controls and inspection evidence across the medicinal-product lifecycle keeps them aligned as things change.
In your words: “Our governance says what should happen, but does not reliably control what people actually do”
Governance that changes tasks, decision thresholds, approvals, escalation and evidence capture is governance you can rely on in operation.
In your words: “Safety-management systems do not reliably shape daily work”
When mitigations, competence, occurrence reporting and assurance are embedded in workflow, the safety-management system shapes daily work.
IGX360 Insights supports mapping, evidence and assurance. Regulatory interpretation and accountability remain with the organisation.
No results found.
Search is temporarily unavailable. Please try again shortly.
Start typing to search the whole site.
Required for the site to function. Always on.
Google Analytics, via Google Tag Manager. Helps us see which pages are useful.